Business · 18/09/2024
FDA Announces Public Meeting of Pharmacy Compounding Advisory Committee to Discuss Bulk Drug Substances
The Food and Drug Administration (FDA) is hosting a public meeting of the Pharmacy Compounding Advisory Committee to gather input on bulk drug substances and to revise the list of withdrawn or removed substances.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →